Live feed16:05:00·738dPRReleasevia QuantisnowASCO Data Highlights NeXT Personal® Ultra-sensitive MRD Performance in Early-stage Breast Cancer Recurrence Detection and Immunotherapy MonitoringByQuantisnow·Wall Street's wire, on your screen.PSNL· Personalis Inc.Health Care
